3 terminated, 2 completed, 1 recruiting. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Terminated 3, Completed 2, Recruiting 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Metastatic Disease: new trials by email Literature Review of Metastatic Disease trials Research Report on Metastatic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma EB-DNK101 dual-targeting CAR-NK cells (MSLN + MUC1), EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1), Lymphodepleting chemotherapy (Flu/Cy) - Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 42 | 2026-03-02 | 2026-06-04 |
| Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients Promitil, EBR - Cancer, Solid Tumor | Phase 1 | Completed | Lipomedix Pharmaceuticals Inc. | 18 | 2019-01-03 | 2022-01-06 |
| Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer AR-42, Pazopanib - Renal Cell Carcinoma, Soft Tissue Sarcoma | Phase 1 | Terminated | Virginia Commonwealth University | 6 | 2016-07-08 | 2019-10-24 |
| BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer BIBW 2992 - Metastatic Disease | Phase 1 | Terminated | Johannes Gutenberg University Mainz | 9 | 2012-08-01 | 2019-09-06 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer Temsirolimus, Casodex (bicalutamide) - Prostate Cancer, Prostatic Neoplasms | Phase 1 / Phase 2 | Terminated | Sandy Srinivas | 5 | 2009-10-01 | 2014-10-13 |
| Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone intensity modulated radiation therapy - Metastatic Disease | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 68 | 2006-08-01 | 2015-11-17 |
Neoplasm Metastasis (6) · Biliary Tract Neoplasms (1) · Carcinoma, Renal Cell (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1)
Neoplastic Processes (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Neoplasms (5) · Neoplasms by Site (4) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Adenocarcinoma (1) · Biliary Tract Diseases (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Afatinib (1) · Cisplatin (1) · Cyclophosphamide (1) · Gemcitabine (1) · HDAC-42 (1) · Radiotherapy, Intensity-Modulated (1) · Transplantation Conditioning (1) · bicalutamide (1) · fludarabine (1) · pazopanib (1) · temsirolimus (1)
Beijing Biotech (1) · Johannes Gutenberg University Mainz (1) · Lipomedix Pharmaceuticals Inc. (1) · Memorial Sloan Kettering Cancer Center (1) · Sandy Srinivas (1) · Virginia Commonwealth University (1)
United States (3) · China (1) · Germany (1) · Israel (1)
Adi Levy, MD (1) · Andrew S Poklepovic, MD (1) · Eli Sapir, MD (1) · Lauren Christine Harshman, MD (1) · Markus Moehler, Prof. Dr. med. (1) · Michael Zelefsky, MD (1)
P30CA016059 (1)